SCHEMBL29616508

SCHEMBL29616508

Cc1cc(Br)cnc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 3/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
PLA2G1B P04054 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
AGBL2 Q5U5Z8 1/20 0.33
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
IDO1 P14902 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
DYRK1A Q13627 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17119433 1.00 S1PR1 (0.37) S1PR1S1PR3SMN1; SMN2HTTKMT2A
SCHEMBL22770846 0.85 S1PR1 (0.36) S1PR1S1PR3SMN1; SMN2HTTKMT2A
SCHEMBL21718950 0.80 S1PR1 (0.38) S1PR1S1PR3SMN1; SMN2HTTKMT2A
SCHEMBL2256015 0.80 KMT2A (0.46) HTTKMT2AALDH1A1PLA2G1BATG4B
SCHEMBL15674471 0.78 CYP11B1 (0.39) HTTKMT2APLA2G1BATG4BIDO1
SCHEMBL13921765 0.77 NOS3 (0.48) HTTAGBL2KDM4EMAPTCYP2A6
SCHEMBL14941390 0.77 KMT2A (0.34) HTTKMT2APLA2G1BATG4BIDO1
SCHEMBL22447739 0.77 KMT2A (0.43) HTTKMT2AALDH1A1PLA2G1BATG4B
SCHEMBL30598681 0.77 KMT2A (0.43) HTTKMT2AALDH1A1PLA2G1BATG4B
SCHEMBL15674757 0.77 PLAU (0.42) SMN1; SMN2HTTKMT2AALDH1A1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111936503-B Oxazine monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2023-09-12 CN disclosed
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 EP disclosed
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 CN disclosed